These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7681318)

  • 1. Gender and response to antilymphocyte globulin (ALG) for severe aplastic anaemia.
    Nissen C; Gratwohl A; Tichelli A; Stebler C; Würsch A; Moser Y; Dalle Carbonare V; Signer E; Buser M; Ritz R
    Br J Haematol; 1993 Feb; 83(2):319-25. PubMed ID: 7681318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party.
    Bacigalupo A; Broccia G; Corda G; Arcese W; Carotenuto M; Gallamini A; Locatelli F; Mori PG; Saracco P; Todeschini G
    Blood; 1995 Mar; 85(5):1348-53. PubMed ID: 7532040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antilymphocyte globulin (ALG) on bone marrow T/non-T cells from aplastic anaemia patients and normal controls.
    Tong J; Bacigalupo A; Piaggio G; Figari O; Marmont A
    Br J Haematol; 1989 Dec; 73(4):546-50. PubMed ID: 2692693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
    Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
    Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphology in patients with severe aplastic anemia treated with antilymphocyte globulin.
    Tichelli A; Gratwohl A; Nissen C; Signer E; Stebler Gysi C; Speck B
    Blood; 1992 Jul; 80(2):337-45. PubMed ID: 1627795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained trilineage response in a patient with ALG-resistant severe aplastic anaemia after treatment with G-CSF, erythropoietin and cyclosporin A: association of recovery with marked elevation of serum alkaline phosphatase.
    Weide R; Lyttelton M; Samson D; Görg C; Köppler H; Pflüger KH; Havemann K
    Br J Haematol; 1993 Nov; 85(3):608-10. PubMed ID: 7510993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete recovery of marrow function after treatment with anti-lymphocyte globulin is associated with high, whereas early failure and development of paroxysmal nocturnal haemoglobinuria are associated with low endogenous G-CSA-release.
    Nissen C; Moser Y; dalle Carbonare V; Gratwohl A; Speck B
    Br J Haematol; 1989 Aug; 72(4):573-7. PubMed ID: 2789075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party.
    Bacigalupo A; Hows J; Gluckman E; Nissen C; Marsh J; Van Lint MT; Congiu M; De Planque MM; Ernst P; McCann S
    Br J Haematol; 1988 Oct; 70(2):177-82. PubMed ID: 3056497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of aplastic anaemia with antilymphocyte globulin (ALG).
    Fairhead SM; Chipping PM; Gordon-Smith EC
    Br J Haematol; 1983 Sep; 55(1):7-16. PubMed ID: 6882689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome.
    Nissen C; Genitsch A; Sendelov S; Dalle Carbonare V; Wodnar-Filipowicz A
    Acta Haematol; 2000; 103(1):33-40. PubMed ID: 10705157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of severe aplastic anemia with antilymphocyte globulin and androgens.
    Gluckman E; Devergie A; Faille A; Barrett AJ; Bonneau M; Boiron M; Bernard J
    Exp Hematol; 1978 Sep; 6(8):679-87. PubMed ID: 361428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent growth impairment of bone marrow stroma after antilymphocyte globulin treatment for severe aplastic anaemia and its association with relapse.
    Nissen C; Wodnar-Filipowicz A; Slanicka Krieger MS; Slanicka Gratwohl A; Tichelli A; Speck B
    Eur J Haematol; 1995 Oct; 55(4):255-61. PubMed ID: 7589344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Di Bona E; Rodeghiero F; Bruno B; Gabbas A; Foa P; Locasciulli A; Rosanelli C; Camba L; Saracco P; Lippi A; Iori AP; Porta F; De Rossi G; Comotti B; Iacopino P; Dufour C; Bacigalupo A
    Br J Haematol; 1999 Nov; 107(2):330-4. PubMed ID: 10583220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune suppression therapy in aplastic anemia: influencing factors on response and survival.
    Jin JY; Kim DW; Lee JW; Han CW; Min WS; Park CW; Kim CC; Kim DJ; Kim HK; Song HH
    Korean J Intern Med; 1995 Jan; 10(1):25-31. PubMed ID: 7626553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of immunosuppressive therapy for aplastic anemia].
    Teramura M; Saito H; Kobayashi S; Hoshino S; Oshimi K; Mizoguchi H
    Rinsho Ketsueki; 1993 Mar; 34(3):273-6. PubMed ID: 7683063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of severe aplastic anemia].
    Gratwohl A; Osterwalder B; Nissen C; Leibundgut U; Signer E; Lüthy A; Jeannet M; Speck B
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1520-2. PubMed ID: 7031870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation.
    Speck B; Gratwohl A; Nissen C; Leibundgut U; Ruggero D; Osterwalder B; Burri HP; Cornu P; Jeannet M
    Br Med J (Clin Res Ed); 1981 Mar; 282(6267):860-3. PubMed ID: 6783204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of antilymphocyte globulin in the treatment of chronic acquired bone marrow failure.
    Marsh JC; Gordon-Smith EC
    Blood Rev; 1988 Sep; 2(3):141-8. PubMed ID: 3052659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT).
    de Planque MM; Bacigalupo A; Würsch A; Hows JM; Devergie A; Frickhofen N; Brand A; Nissen C
    Br J Haematol; 1989 Sep; 73(1):121-6. PubMed ID: 2803967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow graft versus ALG in patients with aplastic anaemia.
    Speck B; Gratwohl A; Nissen C; Osterwalder B; Signer E; Jeannet M
    Biomed Pharmacother; 1983; 37(3):139-43. PubMed ID: 6357304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.